Advertisement

Current Psychiatry Reports

, Volume 8, Issue 1, pp 53–58 | Cite as

Update on pathological gambling

  • Jon E. Grant
  • Kyle A. Williams
  • Suck Won Kim
Article

Abstract

Pathological gambling (PG) is a signi.cant public health concern associated with high rates of psychiatric comorbidity and mortality. Although research into the biology of PG is still in an early stage, recent advances in our understanding of motivation, reward, and addiction have provided substantial insight into the possible pathophysiology of this disorder. In addition, over the past 5 years, extraordinary progress has been made in the area of clinical research examining treatments for PG. Although PG is a disabling disorder that continues to represent a clinical challenge for the healthcare professional, our current knowledge of pharmacotherapy and psychosocial interventions offers potentially effective treatment options.

Keywords

Cocaine Paroxetine Naltrexone Pathological Gambling Gambling Behavior 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Shaffer HJ, Hall MN: Estimating the prevalence of disordered gambling behavior in the United States and Canada: a research synthesis. Am J Public Health 1999, 89:1369–1376.PubMedCrossRefGoogle Scholar
  2. 2.
    Argo T, Black DW: Clinical characteristics. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC: APPI; 2004:39–53.Google Scholar
  3. 3.
    Grant JE, Potenza MN: Pathological gambling and other behavioral addictions. In Clinical Textbook of Addictive Disorders, Third Edition. Edited by Frances RJ, Miller SI, Mack AH. New York: Guildford Press; 2005:303–320.Google Scholar
  4. 4.
    Blanco C, Moreyra P, Nunes EV, et al.: Pathological gambling: addiction or compulsion? Semin Clin Neuropsychiatry 2001, 6:167–176.PubMedCrossRefGoogle Scholar
  5. 5.
    King JA, Tenney J, Rossi V, et al.: Neural substrates underlying impulsivity. Ann N Y Acad Sci 2003, 1008:160–169.PubMedCrossRefGoogle Scholar
  6. 6.
    Martin PR, Petry NM: Are non-substance-related addictions really addictions? Am J Addict 2005, 14:1–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Phillips KA: The obsessive-compulsive spectrums. Psychiatr Clin North Am 2002, 25:791–809.PubMedCrossRefGoogle Scholar
  8. 8.
    Lucki I: The spectrum of behaviors in.uenced by serotonin. Biol Psychiatry 1998, 44:151–162.PubMedCrossRefGoogle Scholar
  9. 9.
    Melis M, Spiga S, Diana M: The dopamine hypothesis of drug addiction: hypodopaminergic state. Int Rev Neurobiol 2005, 63:101–154.PubMedCrossRefGoogle Scholar
  10. 10.
    Hyman SE: Addiction: a disease of learning and memory. Am J Psychiatry 2005, 162:14–22.CrossRefGoogle Scholar
  11. 11.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC: American Psychiatric Association; 2000.CrossRefGoogle Scholar
  12. 12.
    Nader MA, Czoty PW: PET imaging of dopamine D2 receptors in monkey models of cocaine abuse: genetic predisposition versus environmental modulation. Am J Psychiatry 2005, 162:73–82.CrossRefGoogle Scholar
  13. 13.
    Kelley AE: Memory and addiction: shared neural circuitry and molecular mechanisms. Neuron 2004, 44:161–179.PubMedCrossRefGoogle Scholar
  14. 14.
    Kalivas PW, Volkow ND: The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005, 162:03–13. A general review and synthesis of the neurobiology of addiction, with particular focus on the shared neuronal circuitry and neural substrates of choice and reward.CrossRefGoogle Scholar
  15. 15.
    Di Chiara G: The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend 1995, 38:95–137.PubMedCrossRefGoogle Scholar
  16. 16.
    Schultz W: Getting formal with dopamine and reward. Neuron 2002, 36:241–263.PubMedCrossRefGoogle Scholar
  17. 17.
    Tobler PN, Fiorillo CD, Schultz W: Adaptive coding of reward by dopamine neurons. Science 2005, 307:1642–1645.PubMedCrossRefGoogle Scholar
  18. 18.
    Fiorillo CD, Tobler PN, Schultz W: Discrete coding of reward probability and uncertainty by dopamine neurons. Science 2003, 299:1898–1902. This study reported a population of midbrain dopaminergic neurons that show discriminatory responses to both the expectancy and magnitude of reward. Dopaminergic neurons were shown to both a phasic response to reward error prediction and a sustained response to the variation in magnitude of the reward. The highest levels of reward uncertainty were shown to correlate with the most robust activation of dopaminergic neurons.PubMedCrossRefGoogle Scholar
  19. 19.
    Dreher JC, Kohn P, Berman KF: Neural coding of distinct statistical properties of reward information in humans. Cereb Cortex 2005, In press.Google Scholar
  20. 20.
    Crockford DN, Goodyear B, Edwards J, et al.: Cue-induced brain activity in pathological gamblers. Biol Psychiatry 2005, 58:787–795.PubMedCrossRefGoogle Scholar
  21. 21.
    Reuter J, Raedler T, Rose M, et al.: Pathological gambling is linked to reduced activation of the mesolimbic reward system. Nat Neurosci 2005, 8:7–8.CrossRefGoogle Scholar
  22. 22.
    Potenza MN, Leung HC, Blumberg HP, et al.: An FMRI Stroop task study of ventromedial prefrontal cortical function in pathological gamblers. Am J Psychiatry 2003, 160:1990–1904.PubMedCrossRefGoogle Scholar
  23. 23.
    Breiter HC, Aharon I, Kahneman D, et al.: Functional imaging of neural responses to expectancy and experience of monetary gains and losses. Neuron 2001, 30:619–639.PubMedCrossRefGoogle Scholar
  24. 24.
    Breiter HC, Gollub RL, Weisskoff RM, et al.: Acute effects of cocaine on human brain activity and emotion. Neuron 1997, 19:591–611.PubMedCrossRefGoogle Scholar
  25. 25.
    Breiter HC, Becerra L, Gonzalez RG: Morphine induced reward and pain circuitry activation in drug naive humans [poster abstract]. Paper presented at American Pain Society, Atlanta, GA: 2000.Google Scholar
  26. 26.
    Jentsch JD, Taylor JR: Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999, 6:373–390.CrossRefGoogle Scholar
  27. 27.
    Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for involvement of the frontal cortex. Am J Psychiatry 2002, 999:523–528.Google Scholar
  28. 28.
    Volkow ND, Wang G-J, Ma Y, et al.: Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003, 23:161–168.Google Scholar
  29. 29.
    Wexler BE, Gottshalk CH, Fulbright RK, et al.: Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001, 158:86–95.PubMedCrossRefGoogle Scholar
  30. 30.
    Petry NM, Stinson FS, Grant BF: Comorbidity of DSM-IV pathological gambling and other psychiatric disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2005, 66:564–574.PubMedCrossRefGoogle Scholar
  31. 31.
    Shah KR, Potenza MN, Eisen SA: Biological basis for pathological gambling. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC; APPI; 2004.Google Scholar
  32. 32.
    Dodd ML, Klos KJ, Bower JH, et al.: Pathological gambling caused by drugs used to treat Parkinson disease. Arch Neurol 2005, 62:1377–1381.PubMedCrossRefGoogle Scholar
  33. 33.
    Hollander E, DeCaria CM, Finkell JN, et al.: A randomized double-blind fluvox-amine/placebo crossover trial in pathological gambling. Biol Psychiatry 2000, 47:813–817.PubMedCrossRefGoogle Scholar
  34. 34.
    Blanco C, Petkova E, Ibanez A, et al.: A pilot placebocontrolled study of fluvoxamine for pathological gambling. Ann Clin Psychiatry 2002, 14:9–15.PubMedGoogle Scholar
  35. 35.
    Kim SW, Grant JE, Adson DE, et al.: A double-blind placebocontrolled study of the efficacy and safety of paroxetine in the treatment of pathological gambling. J Clin Psychiatry 2002, 63:501–507.PubMedGoogle Scholar
  36. 36.
    Grant JE, Kim SW, Potenza MN, et al.: Paroxetine treatment of pathological gambling: A multi-center randomized controlled trial. Int Clin Psychopharmacol 2003, 18:243–249.PubMedCrossRefGoogle Scholar
  37. 37.
    Saiz-Ruiz J, Blanco C, Ibnaez A, et al.: Sertraline treatment of pathological gambling: a pilot study. J Clin Psychiatry 2005, 66:28–33.PubMedCrossRefGoogle Scholar
  38. 38.
    Potenza MN: The neurobiology of pathological gambling. Semin Clin Neuropsychiatry 2001, 6:217–226.PubMedCrossRefGoogle Scholar
  39. 39.
    Hollander E, Pallanti S, Allen A, et al.: Does sustainedrelease lithium reduce impulsive gambling and affective instability versus placebo in pathological gamblers with bipolar spectrum disorders? Am J Psychiatry 2005, 162:137–145.PubMedCrossRefGoogle Scholar
  40. 40.
    Kim SW, Grant JE, Adson D, Shin YC: Double-blind naltrexone and placebo comparison study in the treatment of pathological gambling. Biol Psychiatry 2001, 49:914–921.PubMedCrossRefGoogle Scholar
  41. 41.
    Grant JE, Potenza MN, Hollander E, et al.: A multicenter investigation of fixed-dose nalmefene in the treatment of pathological gambling [abstract]. Presented at the National Institute of Mental Health NCDEU 45th Annual Meeting. Boca Raton, FL: June 6–9, 2005.Google Scholar
  42. 42.
    Rugle L: The use of olanzapine in the treatment of video poker pathological gamblers [abstract]. Presented at The Comorbidity of Pathological Gambling: A Current Research Synthesis conference. Las Vegas: December 3–5.Google Scholar
  43. 43.
    Hodgins DC, Petry NM: Cognitive and behavioral treatments. In Pathological Gambling: A Clinical Guide to Treatment. Edited by Grant JE, Potenza MN. Washington, DC: APPI; 2004.Google Scholar
  44. 44.
    Eucheburua E, Baez C, Fernandez-Montalvo J: Comparative effectiveness of three therapeutic modalities in psychological treatment of pathological gambling: long term outcome. Behav Cog Psychother 1996, 24:51–72.CrossRefGoogle Scholar
  45. 45.
    Petry NM: Pathological Gambling: Etiology, Comorbidity, and Treatment. Washington, DC: American Psychological Association; 2005. This book provides a thorough review of the literature on pathological gambling and includes a detailed cognitive behavioral manual.CrossRefGoogle Scholar
  46. 46.
    Petry NM: Gamblers Anonymous and cognitive-behavioral therapies for pathological gamblers. J Gambling Stud 2005, 21:27–33.CrossRefGoogle Scholar

Copyright information

© Current Science Inc 2006

Authors and Affiliations

  1. 1.Department of PsychiatryUniversity of Minnesota School of MedicineMinneapolisUSA

Personalised recommendations